Search Results 651-660 of 18169 for Lymphocytic leukemia
This study evaluates CLR 131 in patients with select B-cell malignancies (multiple myeloma( MM), indolent chronic lymphocytic leukemia (CLL)/small lymphocytic ...
... lymphocytic leukemia (CLL) risk across African Americans, Hispanics, and Caucasian populations. A Study of Nab-Paclitaxel as Maintenance Treatment After ...
... lymphocytic leukemia, Acute myelogenous leukemia, Non-Hodgkin lymph...oma, Hodgkin lymphoma, Aplastic anemia, Diffuse large b-cell lymphoma, Follicular ...
All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...
... Lymphocytic Leukemia. Jacksonville, Fla. This open-label, randomized study will compare the efficacy of GDC-0199 plus rituximab (GDC-0199+R) with ...
... lymphocytic leukemia, M...yelodysplastic syndromes, Myelofibrosis, Acute myelogenous leukemia, Chronic myelogenous leukemia, Aplastic anemia, Leukemia ...
Analysis of the clonal heterogeneity and its evolution in patients with chronic lymphocytic leukemia at disease progression and after relapse of therapy ...
Blood Cancers & Disorders Discussions. hikerny · Anyone have chronic lymphocytic leukemia (CLL)?. 176 Replies Mon, Mar 16, 2026.
Obinutuzumab injection is used together with other medicines (eg, chlorambucil) to treat chronic lymphocytic leukemia (CLL). This medicine is also used to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.